salmeterol/fluticasone cipla 25 mikrog / 250 mikrog
cipla europe nv - salmeterolxinafoat / flutikasonpropionat - inhalasjonsaerosol, suspensjon - 25 mikrog / 250 mikrog
imatinib cipla 400 mg
cipla europe nv - imatinibmesilat - kapsel, hard - 400 mg
imatinib cipla 100 mg
cipla europe nv - imatinibmesilat - kapsel, hard - 100 mg
bosentan cipla 125 mg
cipla europe nv - bosentanmonohydrat - tablett, filmdrasjert - 125 mg
bosentan cipla 62.5 mg
cipla europe nv - bosentanmonohydrat - tablett, filmdrasjert - 62.5 mg
rekambys
janssen-cilag international nv - rilpivirine - hiv-infeksjoner - antivirale midler til systemisk bruk - rekambys is indicated, in combination with cabotegravir injection, for the treatment of human immunodeficiency virus type 1 (hiv 1) infection in adults who are virologically suppressed (hiv-1 rna < 50 copies/ml) on a stable antiretroviral regimen without present or past evidence of viral resistance to, and no prior virological failure with, agents of the nnrti and ini class.
tadalafil cipla 20 mg
cipla europe nv - tadalafil - tablett, filmdrasjert - 20 mg
tadalafil cipla 2.5 mg
cipla europe nv - tadalafil - tablett, filmdrasjert - 2.5 mg
tadalafil cipla 5 mg
cipla europe nv - tadalafil - tablett, filmdrasjert - 5 mg
tadalafil cipla 10 mg
cipla europe nv - tadalafil - tablett, filmdrasjert - 10 mg